ロード中...

All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitors could effectively reduce HbA(1C) and postprandial hyperglycemia and could incur only minimal danger of hypoglycemia. Patients with uncontrolled diabetes might be treated by the complementary action of insulin plus DPP-4 inhibitors. Here, we compa...

詳細記述

保存先:
書誌詳細
出版年:BMC Endocr Disord
主要な著者: Yen, Fu-Shun, Chiang, Jen-Huai, Hwu, Chii-Min, Yen, Yu-Hsin, Lin, Boniface J., Wei, James Cheng-Chung, Hsu, Chih-Cheng
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6321656/
https://ncbi.nlm.nih.gov/pubmed/30611254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-018-0330-7
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!